ORASURE TECHNOLOGIES, INC Shareholders' Equity
ORASURE TECHNOLOGIES, INC (OSUR) had Shareholders' Equity of $317.78 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-07
- 2026-06-30: Stockholders' Equity Attributable to Parent $317.78M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $313.32M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $340.83M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $361.98M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $317.78M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $313.32M 10-Q · filed 2026-08-07 | |
| 2025-12-31 | $340.83M 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $361.98M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $380.72M 10-Q · filed 2026-08-07 | |
| 2025-03-31 | $396.28M 10-Q · filed 2026-08-07 | |
| 2024-12-31 | $410.34M 10-Q · filed 2026-08-07 | |
| 2024-09-30 | $425.56M 10-Q · filed 2025-11-05 | |
| 2024-06-30 | $425.84M 10-Q · filed 2025-11-05 | |
| 2024-03-31 | $426.25M 10-Q · filed 2025-11-05 | |
| 2023-12-31 | $430.67M 10-K · filed 2026-03-09 | |
| 2023-09-30 | $404.88M 10-Q · filed 2024-11-06 | |
| 2023-06-30 | $394.14M 10-Q · filed 2024-11-06 | |
| 2023-03-31 | $394.18M 10-Q · filed 2024-11-06 | |
| 2022-12-31 | $364.43M 10-K · filed 2026-03-09 | $363.62M 10-K · filed 2023-03-03 |
| 2022-09-30 | $342.45M 10-Q · filed 2023-11-08 | $341.89M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $344.43M 10-Q · filed 2023-11-08 | $344.19M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $364.91M 10-Q · filed 2023-11-08 | $364.89M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $380.53M 10-K · filed 2025-03-07 | |
| 2021-09-30 | $387.82M 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $404.82M 10-Q · filed 2022-11-08 | |
| 2021-03-31 | $403.54M 10-Q · filed 2022-11-08 | |
| 2020-12-31 | $398.57M 10-K · filed 2024-03-11 | |
| 2020-09-30 | $387.89M 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $381.76M 10-Q · filed 2021-11-04 | |
| 2020-03-31 | $290.15M 10-Q · filed 2021-11-04 | |
| 2019-12-31 | $307.14M 10-K · filed 2023-03-03 | |
| 2019-09-30 | $301.37M 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $288.22M 10-Q · filed 2020-11-05 | |
| 2019-03-31 | $280.51M 10-Q · filed 2020-11-05 | |
| 2018-12-31 | $283.38M 10-K · filed 2022-03-01 | |
| 2018-09-30 | $276.75M 10-Q · filed 2019-11-08 | |
| 2018-06-30 | $265.17M 10-Q · filed 2019-11-08 | |
| 2018-03-31 | $258.72M 10-Q · filed 2019-11-08 | $258.72M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $258.08M 10-K · filed 2021-03-01 | |
| 2017-09-30 | $249.51M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $229.41M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $208.82M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $185.85M 10-K · filed 2020-03-02 | |
| 2016-09-30 | $176.48M 10-Q · filed 2016-11-08 | |
| 2016-06-30 | $168.79M 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $163.01M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $159.44M 10-K · filed 2019-02-28 | |
| 2015-09-30 | $160.00M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $159.85M 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $155.83M 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $158.70M 10-K · filed 2018-02-28 | |
| 2014-09-30 | $160.92M 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $160.32M 10-Q · filed 2014-08-06 | |
| 2014-03-31 | $154.71M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $161.15M 10-K · filed 2017-03-14 | |
| 2013-09-30 | $154.89M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $154.55M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $159.92M 10-Q · filed 2013-05-09 | |
| 2013-01-01 | $170.31M 10-K · filed 2016-03-14 | |
| 2012-12-31 | $170.31M 10-K · filed 2015-03-12 | |
| 2012-09-30 | $174.78M 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $98.84M 10-Q · filed 2012-08-08 | |
| 2012-03-31 | $100.29M 10-Q · filed 2012-05-09 | |
| 2011-12-31 | $100.25M 10-K · filed 2015-03-12 | $100.25M 10-K · filed 2012-03-14 |
| 2011-09-30 | $95.97M 10-Q · filed 2011-11-09 | |
| 2011-06-30 | $101.20M 10-Q · filed 2011-08-05 | |
| 2010-12-31 | $102.84M 10-K · filed 2014-03-14 | $102.84M 10-Q · filed 2011-08-05 |
| 2009-12-31 | $103.81M 10-K · filed 2013-03-13 | $103.81M 10-K · filed 2012-03-14 |
| 2008-12-31 | $108.33M 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |